A subscription to JoVE is required to view this content. Sign in or start your free trial.
Porous substrate electroporation (PSEP) pairs consistent, high throughput delivery with high cell viability. Introduction of transepithelial electrical impedance (TEEI) measurements provides insight into the intermediate processes of PSEP and allows for label-free delivery. This article discusses a method for performing PSEP delivery experiments and TEEI measurement analysis simultaneously.
Porous substrate electroporation (PSEP) is an emerging method of electroporation that provides high throughput and consistent delivery. Like many other types of intracellular delivery, PSEP relies heavily on fluorescent markers and fluorescent microscopy to determine successful delivery. To gain insight into the intermediate steps of the electroporation process, a PSEP platform with integrated transepithelial electrical impedance (TEEI) monitoring was developed. Cells are cultured in commercially available inserts with porous membranes. After a 12 h incubation period to allow for the formation of a fully confluent cell monolayer, the inserts are placed in transfection media located in the wells of the PSEP device. The cell monolayers are then subjected to a user-defined waveform, and delivery efficiency is confirmed through fluorescent microscopy. This workflow can be significantly enhanced with TEEI measurements between pulsing and fluorescent microscopy to collect additional data on the PSEP process, and this additional TEEI data is correlated with delivery metrics such as delivery efficiency and viability. This article describes a protocol for performing PSEP with TEEI measurements.
Electroporation is a technique in which cells are exposed to an electric field, creating temporary pores in the cell membrane through which cargos, including proteins, RNA, and DNA, can pass1,2. The most widely used version is bulk electroporation (BEP). BEP is performed by filling a cuvette with an electrolyte containing millions of cells, exposing the electrolyte to high voltage, and allowing cargo to enter the cells through diffusion or endocytosis1. There are many advantages to BEP, including high throughput and numerous commercially available systems. However, there are limitations to the BEP delivery. Inconsistent cell positioning relative to the electrodes and electric field shielding from adjacent cells causes significant variability in electric field exposure during BEP3,4. The high voltage required for BEP also has a significant negative impact on cell viability5. Since its inception in 20116, there has been growing interest in an electroporation method called porous substrate electroporation (PSEP), though it is sometimes referred to by other names, including localized electroporation and nano- or micro-electroporation1,7,8. In contrast to the cell suspension of BEP, PSEP is conducted on cells that are adherent to a porous substrate. Not only is an adherent state preferred for the majority of human cell lines9, but the pores in the substrate also focus on the electric current, localizing the transmembrane electrical potential (TMP) to specific regions of the cell membrane10,11. This localization allows for a significant reduction in applied voltage, decreasing damage and increasing cell viability. This combination of effects helps control cell membrane pore development, resulting in a more consistent and efficient delivery1,5,12.
A recent study introduced a PSEP device with a six-well, gold-plated electrode array for holding commercially available porous membrane inserts13 (Figure 1A,B), a practice that was first introduced by Vindis et al.14. The device can apply pulses and measure the electrical impedance across the cell monolayer, known as the transepithelial electrical impedance (TEEI), in real-time13. The user interface of the device allows complete control over the electroporation waveform and polarity. Importantly, real-time impedance measurements can be used to predict delivery outcomes without the need for expensive reagents or fluorescent markers, a concept known as label-free delivery15.
The PSEP platform consists of two major custom electrical components: the main body of the device, which houses the pulse generator and TEEI measurement equipment, and the electrode array, where the porous substrates are inserted, and the electroporation occurs. Diagrams for all custom electronics and 3D-printed components can be found at GitHub:Β https://github.com/YangLabUNL/PSEP-TEEI. In addition to the custom electronics, a computer is also required for the platform to function properly. The custom software requires MATLAB (version 2021a or later) to run, and Microsoft Excel to store and access data for analysis. The program controls the custom electronics and provides the graphical user interface (GUI) for adjusting settings. These programs were also made available at GitHub: https://github.com/YangLabUNL/PSEP-TEEI.
Preliminary data suggests this process is possible for different types of adherent cells (Figure 1C), but this article will only discuss the preparation of A431 cells using parameters that were found to be optimal for this cell line by Brooks et al.13. Additionally, because the propidium iodide (PI) cargo is cytotoxic, two experiments are performed, the first with a high concentration PI transfection media to quantify delivery efficiency, and the second with only cell culture media to measure TEEI over longer timescales. These experiments use identical electroporation waveforms, allowing the results to be correlated (Figure 1D).
Figure 1: Electrode array assembly diagram and foundational data. (A) CAD model of an insert inside a well of the electrode array. (B) CAD model of the electrode array. (C) Impedance increase due to PSEP for select cell lines, n = 3 per cell line. Error bar: standard error of the mean. (D) Delivery efficiency vs. TEEI increase correlation data. Delivery efficiency was calculated by dividing the number of cells labeled in both PI and calcein images from delivery experiments by the total number of cells identified with Hoechst. Cell count was determined using a custom CellProfiler pipeline, n = 6 per voltage. Error bar: (x- and y-axis) standard error of the mean. This figure is reproduced from Brooks et al.13 with permission. Please click here to view a larger version of this figure.
The details of the reagents and the equipment used in the study are listed in the Table of Materials.
1. Preparation of reagents and cell culture
2. Sample preparation
3. Experimental procedure
4. Data analysis
The given protocol establishes a method for using TEEI measurements to examine the intermediate processes of electroporation and make delivery predictions, specifically for the A431 cell line and PI cargo. While modification of this protocol is discussed further in the article, it is important to note now that while the specific values may change, general trends in the response remain consistent. For example, TEEI data that dips below the initial baseline corresponds with cell death, while the maximum increase in TEEI va...
Figure 2C demonstrates that TEEI increases from minimum and decreases from baseline are plotted for each PSEP waveform voltage. The TEEI increase creates a parabolic arc, peaking around 20 volts before reducing, while the TEEI decrease from baseline increases exponentially as voltage increases. The delivery efficiency and death percentages in Figure 2D mirror these trends, with delivery efficiency arcing parabolically, peaking around 30 volts, and death increasi...
The authors declare no conflict of interest.
We acknowledge the funding support from the NSF (Awards 1826135, 1936065, 2143997), the NIH National Institutes of General Medical Sciences P20GM113126 (Nebraska Center for Integrated Biomolecular Communication) and P30GM127200 (Nebraska Center for Nanomedicine), the Nebraska Collaborative Initiative and the Voelte-Keegan Bioengineering Support. The device was manufactured at the NanoEngineering Research Core Facility (NERCF), which is partially funded by the Nebraska Research Initiative.
Name | Company | Catalog Number | Comments |
15 mL Conical Centrifuge Tube | Thermo Scientific | 339651 | |
2-Chip Disposable Hemocytometer | Bulldog Bio | DHC-N01 | |
75 cm2 Tissue Culture Flask | fisherbrand | FB012937 | |
A431 Cells | ATCC | CRL-1555 | |
Calcein AM | Invitrogen | C3099 | |
Class II Type A2 Biosafety Cabinet | Labgard | NU-543-600 | |
Custom Components | YangLab | https://github.com/YangLabUNL/PSEP-TEEI | |
Disposable Centrifuge Tube (50 mL) | fisherbrand | 05-539-6 | |
DMEM | Gibco | 11965092 | |
Fetal Bovine Serum | Gibco | A5670401 | |
Fluid Aspiration System | vacuubrand | 20727403 | |
HERACELL 240i | Thermo Scientific | 51026331 | |
Hoechst 33342 | Thermo Scientific | 62249 | |
Human Plasma Fibronectin | Sigma-Aldrich | FIBRP-RO | |
Inverted Fluorescent Microscope | Zeiss | 491916-0001-000 | |
Inverted Microscope | Labomed | TCM 400 | |
PBS | cytiva | SH30256.02 | |
PCR Tube 200 Β΅L | Sarstedt | 72.737 | |
Penicillin / Streptomycin | Gibco | 15140148 | |
Pipette (0.2-2 Β΅L) | fisherbrand Elite | FBE00002 | |
Pipette (100-1000 Β΅L) | fisherbrand Elite | FBE01000 | |
Pipette (20-200 Β΅L) | fisherbrand Elite | FBE00200 | |
Pipette (2-20 Β΅L) | fisherbrand Elite | FBE00020 | |
Propidium Iodide | Invitrogen | P1304MP | |
Reaction Tube 1.5 mL | Sarstedt | 72.690.300 | |
Sorvall ST 16R Centrifuge | Thermo Scientific | 75004240 | |
Thincert (24-well) | Greiner Bio-One | 662 641 | 0.4 Β΅m pore diameter, 2x106 cm-2 pore density, transparent PET |
Tissue Culture Plate (24-well) | fisherbrand | FB012929 | |
Trypan Blue Solution | Sigma-Aldrich | T8154-20mL | |
Trypsin | Gibco | 15090046 |
Request permission to reuse the text or figures of this JoVE article
Request PermissionExplore More Articles
This article has been published
Video Coming Soon
Copyright Β© 2025 MyJoVE Corporation. All rights reserved